Presented by: Preben Rasmussen, PhD and Jakob Poulsen, PhD, VALUA ApS The US market is arguably the most interesting target for most Life-Science companies. US patent law differs markedly from the rest of the world. Thus, a short-term myopic focus on the possibilities for obtaining patent protection in the US